BenzingaAugust 12, 2026 at 7:38 AM NY23 days ago

Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $19

Morgan Stanley analyst Terence Flynn maintains Biohaven (NYSE:BHVN) with a Overweight and raises the price target from $18 to $19.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga

Companies in This Story